<DOC>
	<DOCNO>NCT02172417</DOCNO>
	<brief_summary>Study investigate effect inhibition renal cationic drug transporter single dose pharmacokinetics intravenous tiotropium subject age close typical Chronic Obstructive Pulmonary Disease ( COPD ) population</brief_summary>
	<brief_title>Tiotropium Combination With Concomitant Cimetidine Ranitidine Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Healthy male female Age range 50 65 year Within 20 % normal weight ( Broca index ) Any find medical examination ( include blood pressure , puls rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( ≥ 24 hour ) within ten halflives respective drug enrolment study study ( exclusion : ovarian hormone substitution ) Use drug might influence result trial within four week prior administration trial , among nonselective βblockers , cromolyn sodium , nedocromil sodium , oral βadrenergics longacting βadrenergics salmeterol formoterol , anticholinergic drug include ATROVENT® ( ipratropium ) oral inhalation ATROVENT® Nasal Spray Participation another study investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Inability refrain smoke study day Alcohol abuse ( &gt; 40 g/day ) Drug abuse Blood donation ( ≥ 100 ml ) within four week prior administration trial Excessive physical activity within 5 day prior administration trial Any laboratory value outside reference range clinical relevance Subjects know hypersensitivity anticholinergic drug Subjects know symptomatic prostatic hypertrophy disturb micturition Subjects know narrowangle glaucoma In addition female subject ( appropriate ) : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraceptive , sterilization , intra uterine pessary ( IUP ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>